Primary Hypercholesterolemia or Mixed Dyslipidemia
2 clinical trials · Condition
◉ Watch Primary Hypercholesterolemia or Mixed Dyslipidemia
| Record | Firm | Date |
|---|---|---|
| Leqvio rPMS (Regulatory Post-Marketing Surveillance in Korea) (NCT06770543) | Novartis Pharmaceuticals | 2025-08-13 |
| Efficacy and Safety of Inclisiran as Monotherapy in Chinese Adults With Low or Moderate ASCVD Risk and Elevated Low-density Lipoprotein Cholesterol. (NCT05888103) | Novartis Pharmaceuticals | 2023-07-11 |
Track Primary Hypercholesterolemia or Mixed Dyslipidemia automatically
Every clearance here is in the API, with alerts when new ones post.